Effect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 diabetes: Results from the look AHEAD randomized trial

被引:66
|
作者
Schwartz, Ann V. [1 ]
Johnson, Karen C. [2 ]
Kahn, Steven E. [3 ,4 ]
Shepherd, John A. [5 ]
Nevitt, Michael C. [1 ]
Peters, Anne L. [6 ]
Walkup, Michael P. [7 ]
Hodges, Amelia [7 ]
Williams, Carrie C. [7 ]
Bray, George A. [8 ]
机构
[1] Univ Calif San Francisco, Dept Biostat & Epidemiol, San Francisco, CA 94107 USA
[2] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA
[3] VA Puget Sound Hlth Care Syst, Dept Med, Div Metab Endocrinol & Nutr, Seattle, WA USA
[4] Univ Washington, Seattle, WA 98195 USA
[5] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94107 USA
[6] Keck Sch Med USC, Div Endocrinol, Dept Med, Los Angeles, CA USA
[7] Wake Forest Univ Hlth Sci, Div Publ Hlth Sci, Dept Biostat Sci, Winston Salem, NC USA
[8] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA
基金
美国国家卫生研究院;
关键词
BONE MINERAL DENSITY; WEIGHT LOSS; TYPE; 2; DIABETES; OBESITY; GLYCEMIC CONTROL; PHYSICAL FITNESS; OVERWEIGHT POSTMENOPAUSAL WOMEN; LIFE-STYLE INTERVENTION; X-RAY ABSORPTIOMETRY; FRACTURE RISK; CARDIOVASCULAR-DISEASE; HIP FRACTURE; OLDER WOMEN; BODY-WEIGHT; MASS; ADULTS;
D O I
10.1002/jbmr.1483
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Intentional weight loss is an important component of treatment for overweight patients with type 2 diabetes, but the effects on bone density are not known. We used data from the Look AHEAD trial to determine the impact of an intensive lifestyle weight loss intervention (ILI) compared with diabetes support and education (DSE) on changes in bone mineral density (BMD) over 12 months. Overweight and obese adults with type 2 diabetes were randomly assigned to ILI or DSE. In a substudy of BMD conducted at 5 of 16 clinical centers, hip, spine, and whole body dual X-ray absorptiometry scans were obtained at baseline and 1-year later on 642 of 739 ILI and 632 of 740 DSE participants. At baseline, mean age was 58.4 years, and average body mass index was 35.2?kg/m2. Total hip BMD T-score was <-2.5 in 1% and <-1.0 in 8%. At 1 year, weight loss was greater in ILI than DSE (-8.6% versus -0.7%), and glycemic control and fitness were also improved. Bone loss over 1 year was greater in ILI at the total hip (-1.4% versus -0.4%; p?<?0.001) and femoral neck (-1.5% versus -0.8%; p?=?0.009), but change in BMD for the lumbar spine and whole body did not differ between groups. In ILI, bone loss at the total hip was independently associated with weight loss in men and women and with poorer glycemic control in men, but was not associated with changes in fitness. One year of an intensive lifestyle intervention in adults with type 2 diabetes, resulting in weight loss, was associated with a modest increase in hip bone loss despite improved fitness and glycemic control. (c) 2012 American Society for Bone and Mineral Research
引用
收藏
页码:619 / 627
页数:9
相关论文
共 50 条
  • [21] Prospective association of a genetic risk score and lifestyle intervention with cardiovascular morbidity and mortality among individuals with type 2 diabetes: the Look AHEAD randomised controlled trial
    McCaffery, Jeanne M.
    Anderson, Andrea
    Bantle, John P.
    Berkowitz, Robert I.
    Bray, George A.
    Cheskin, Lawrence
    Clark, Jeanne M.
    Curtis, Jeffrey M.
    Delahanty, Linda M.
    Evans, Mary
    Foreyt, John P.
    Glasser, Stephen
    Gregg, Edward W.
    Hanson, Robert L.
    Hazuda, Helen P.
    Hill, James O.
    Horton, Edward S.
    Huggins, Gordon S.
    Jakicic, John M.
    Jeffery, Robert W.
    Johnson, Karen C.
    Kahn, Steven E.
    Kelley, David E.
    Kitabchi, Abbas E.
    Knowler, William C.
    Lewis, Cora E.
    Montez, Maria G.
    Kure, Anne
    Nathan, David M.
    Nyenwe, Ebenezer
    Pajewski, Nicholas M.
    Papandonatos, George D.
    Patricio, Jennifer
    Peter, Inga
    Peters, Anne
    Pi-Sunyer, Xavier
    Pownall, Henry
    Wadden, Thomas A.
    Wagenknecht, Lynne E.
    Wing, Rena R.
    Wyatt, Holly
    DIABETOLOGIA, 2015, 58 (08) : 1803 - 1813
  • [22] Fiber Intake and Plasminogen Activator Inhibitor-1 in Type 2 Diabetes: Look AHEAD (Action for Health in Diabetes) Trial Findings at Baseline and Year 1
    Belalcazar, L. Maria
    Anderson, Andrea M.
    Lang, Wei
    Schwenke, Dawn C.
    Haffner, Steven M.
    Yatsuya, Hiroshi
    Rushing, Julia
    Vitolins, Mara Z.
    Reeves, Rebecca
    Pi-Sunyer, Xavier
    Tracy, Russell P.
    Ballantyne, Christie M.
    JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS, 2014, 114 (11) : 1800 - +
  • [23] Predictors of Insulin Initiation in Patients with Type 2 Diabetes: An Analysis of the Look AHEAD Randomized Trial
    Pilla, Scott J.
    Yeh, Hsin-Chieh
    Juraschek, Stephen P.
    Clark, Jeanne M.
    Maruthur, Nisa M.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2018, 33 (06) : 839 - 846
  • [24] Bone mineral density spectrum in individuals with type 1 diabetes, latent autoimmune diabetes in adults, and type 2 diabetes
    Hu, Yuhang
    Li, Xia
    Yan, Xiang
    Huang, Gan
    Dai, Ruchun
    Zhou, Zhiguang
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2021, 37 (03)
  • [25] Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: The Look AHEAD randomized trial
    Alonso, Alvaro
    Bahnson, Judy L.
    Gaussoin, Sarah A.
    Bertoni, Alain G.
    Johnson, Karen C.
    Lewis, Cora E.
    Vetter, Marion
    Mantzoros, Christos S.
    Jeffery, Robert W.
    Soliman, Elsayed Z.
    AMERICAN HEART JOURNAL, 2015, 170 (04) : 770 - +
  • [26] Effect of improved fitness beyond weight loss on cardiovascular risk factors in individuals with type 2 diabetes in the Look AHEAD study
    Gibbs, Bethany Barone
    Brancati, Frederick L.
    Chen, Haiying
    Coday, Mace
    Jakicic, John M.
    Lewis, Cora E.
    Stewart, Kerry J.
    Clark, Jeanne M.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2014, 21 (05) : 608 - 617
  • [27] Type 2 diabetes remission 1 year after an intensive lifestyle intervention: A secondary analysis of a randomized clinical trial
    Ried-Larsen, Mathias
    Johansen, Mette Y.
    MacDonald, Christopher S.
    Hansen, Katrine B.
    Christensen, Robin
    Wedell-Neergaard, Anne-Sophie
    Pilmark, Nanna Skytt
    Langberg, Henning
    Vaag, Allan A.
    Pedersen, Bente K.
    Karstoft, Kristian
    DIABETES OBESITY & METABOLISM, 2019, 21 (10): : 2257 - 2266
  • [28] Heterogeneity of Treatment Effects From an Intensive Lifestyle Weight Loss Intervention on Cardiovascular Events in Patients With Type 2 Diabetes: Data From the Look AHEAD Trial
    de Vries, Tamar, I
    Dorresteijn, Jannick A. N.
    van der Graaf, Yolanda
    Visserem, Frank L. J.
    Westerink, Jan
    DIABETES CARE, 2019, 42 (10) : 1988 - 1994
  • [29] Weight Loss Differentially Impacts Sex Hormones in Women and Men With Type 2 Diabetes: Look AHEAD Sex Hormone Study
    Bennett, Wendy L.
    He, Jiahuan Helen
    Michos, Erin D.
    Kalyani, Rita R.
    Clark, Jeanne M.
    Woodward, Mark
    Syed, Nazia
    Ma, Jianqiao
    Everett, Allen D.
    Yang, Jun
    Graham, David
    Ellis, Greg
    Vaidya, Dhananjay
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024,
  • [30] Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial
    Knowler, W. C.
    Bahnson, J. L.
    Bantle, J. P.
    Bertoni, A. G.
    Bray, G. A.
    Chen, H.
    Cheskin, L.
    Clark, J. M.
    Egan, C.
    Evans, M.
    Foreyt, J. P.
    Glasser, S. P.
    Greenway, F. L.
    Gregg, E. W.
    Hazuda, H. P.
    Hill, J. O.
    Horton, E. S.
    Hubbard, V. S.
    Jakicic, J. M.
    Jeffery, R. W.
    Johnson, K. C.
    Kahn, S. E.
    Kitabchi, A. E.
    Korytkowski, M.
    Krakoff, J.
    Kure, A.
    Lewis, C. E.
    Maschak-Carey, B. J.
    Michaels, S.
    Montez, M. G.
    Nathan, D. M.
    Nyenwe, E.
    Patricio, J.
    Peters, A.
    Pi-Sunyer, X.
    Pownall, H.
    Wadden, T. A.
    Wagenknecht, L. E.
    Williamson, D. F.
    Wing, R. R.
    Wyatt, H.
    Yanovski, S. Z.
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (10): : 801 - 809